UNC5D and metastatic prostate carcinoma: More and more attention has been paid to the inhibition of UNC5 receptor and its biological function in human malignant tumors, UNC5D could be a potential diagnostic biomarker and therapeutic target for metastatic prostate cancer (PCa) [39].